XTSE
KPT
Market cap93mUSD
Jul 09, Last price
13.20CAD
1D
0.46%
1Q
18.07%
Jan 2017
-15.76%
IPO
-23.92%
Name
KP Tissue Inc
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Mississauga, Canada, and incorporated in 2012, KP Tissue Inc. plays a significant role in the disposable tissue market. Through its ownership interest in Kruger Products L.P., the company is involved in the manufacturing, distribution, marketing, and sale of a diverse range of tissue products across both Canada and the United States. Its operations are structured into two distinct segments: Consumer and Away-From-Home. The product portfolio includes essential items such as bathroom and facial tissues, paper towels, and napkins, in addition to manufacturing private label tissue solutions for other brands. These products are sold under well-known brand names like Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, and Metro. KP Tissue reaches its consumer base through conventional retail channels, including grocery stores, mass merchants, club stores, drugstores, convenience outlets, and online platforms. For commercial users, including those in property management, healthcare, food services, manufacturing, lodging industries, and public facilities, products are supplied via a network of distributors.
IPO date
Dec 12, 2012
Employees
2,700
Domiciled in
CA
Incorporated in
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||